secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001213900-23-059806
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive regains Nasdaq minimum market value compliance
--------------------------------------------------------

- Received non-compliance notice on May 17, 2023 for MVLS below $35M.
- MVLS remained above $35M for 10 consecutive business days ending July 24.
- Nasdaq confirmed compliance on July 25, 2023.
- Delisting risk removed; stock continues trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023059806/0001213900-23-059806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023059806/ea182337-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-059806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer